Notifications
Back
IR News

[Investor Updates]PharmAbcine 2021 1Q IR letter

30 Mar 2021
Title
PharmAbcine 2021 1Q IR letter
Category
Investor Updates


< FAQs from the investor meetings as of April 2021 > PharmAbcine, non-confidential slide deck Q4 2020
List New post




     2F, Research Building 2, 70,

     Yuseong-daero 1689 beon-gil,
     Yuseong-gu, Daejeon, 34047, Republic of Korea


     HQ +82-42-863-2017 

     R&D Center +82-42-861-2017

     Investor Relations +70-4294-6097 

     FAX +82-42-863-2080 


     COPYRIGHT BY PharmAbcine Inc.

     ALL RIGHTS RESERVE